Navigation Links
Nation's #1 Respiratory Hospital Enters Agreement to Co-Promote IgE Blood Testing
Date:10/31/2008

- Partnership Underscores Role of Allergy Testing in Improving Asthma

Outcomes -

DENVER, Oct. 31 /PRNewswire/ -- National Jewish Health announced today that it has entered a co-promotion agreement with Phadia, US Inc. to build recognition of the important role allergy testing plays in the diagnosis and treatment of asthma and other respiratory diseases. Under the agreement, National Jewish Health will help create educational programs, activities and literature to promote to pulmonologists the value of understanding allergy in the diagnosis and management of patients with respiratory diseases. National Jewish will discuss available methodologies for in-office testing for allergies in these patients. Phadia currently has a product for such testing in the office, ImmunoCAP Rapid, which is currently under review by the United States Food and Drug Administration (FDA). Phadia anticipates FDA clearance by the end of the first quarter of 2009.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080711/DC27335LOGO)

"National Jewish Health is devoted to combating the uncontrolled asthma epidemic in the United States, and access in our clinics and regional sites to the latest technology will further accelerate our success," said David Tinkelman, MD, Vice President of Health Initiatives at National Jewish. "Our expertise will be invaluable in creating educational opportunities for this important part of the assessment of patients with respiratory diseases."

National Jewish will develop educational services and materials emphasizing the importance and utility of testing patients for allergy in the office setting for pulmonologists. Those services include many elements, but importantly a website for both consumers and physicians who can seek advice and assistance for treatment and avoidance options.

According to the American Academy of Allergy, Asthma and Immunology, approximately 23 million Americans have asthma and more than seven million of these are children, making it one of the most common chronic diseases of childhood. While the number of asthma-related deaths has declined in recent years, asthma remains the cause for nearly two million emergency room visits annually, resulting in a significant economic burden on our healthcare system.

National Jewish Health is known worldwide for treatment of patients with respiratory, immune and related disorders, and for groundbreaking medical research. For 11 consecutive years, U.S. News & World Report has ranked National Jewish the No. 1 respiratory hospital in the nation. National Jewish's Advanced Diagnostics Lab is the nation's leading immunology reference lab, featuring a comprehensive menu of respiratory, molecular, and companion diagnostic tests. More information can be found by visiting http://www.nationaljewish.org.

About Phadia

Phadia AB , headquartered in Uppsala, Sweden , is the world leader in in vitro IgE diagnostic research and product development. Its U.S. affiliate is in Portage, Michigan. More information can be found by visiting http://www.phadia.com


'/>"/>
SOURCE National Jewish Health
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Growing Number of U.S. Kids Not Getting Needed Vaccinations
2. Flu Vaccinations Begin on September 29 Maxim Health Systems to Provide 24,000 Flu Shot Clinics Nationwide
3. Whole Foods Market(R) Donates $25,000, for Midwest Farmers - Hoping to Match an Additional $10,000, via Customer Donations
4. New Report Says a Pandemic is Overdue, But Companies and Nations are ill Prepared to Cope With the Impact
5. Women Deliver Conference to Feature United Nations Leaders
6. New transfusion rules restrict donations from previously pregnant women
7. PA Governor Rendell Announces Latest Nominations and Appointments
8. Wide income gap linked to deaths in both rich and poor nations
9. Shareholder Proposals and Director Nominations Due November 5, 2007
10. United Animal Nations Offers Financial Assistance Grants of up to $500 to Help Southern California Fire Victims Obtain Vet Care, Temporary Boarding for Pets
11. First United Nations World Diabetes Day Unites Global Diabetes Community to Fight the Epidemic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... 10, 2016 , ... Early this week, Team Iconic at J. Walter Thompson ... as the first global confectionery brand sourced from 100% sustainable cocoa. , The Nestlé ... their product, through activities that focus on better farming, better lives and better cocoa. ...
(Date:2/10/2016)... ... ... As part of its ongoing series of aquatic therapy related webinars, HydroWorx ... dynamic expert and thoughtful presentation to give attendees a better sense of how to ... free to attend, but registration is required. , Rehabilitation of Offensive Lineman ...
(Date:2/10/2016)... ... February 10, 2016 , ... Emergency rooms provide emergency ... find. Unfortunately, this can leave patients with dental emergencies at risk of losing a ... offering emergency dental care. , Common dental emergencies include:, , ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... will bring together more than 200 of the country’s top healthcare executives to ... , “The true benefit of the Forum is the provider-centric perspective, experience, expertise ...
(Date:2/10/2016)... ... February 10, 2016 , ... AHRA: ... winner and inspirational speaker Jan Fox will serve as keynote speaker at the ... provide participants with tools to more effectively communicate with their own organizational staff ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... 10, 2016  Rich Pharmaceuticals, Inc. (OTC Markets: RCHA) ... reverse split of its issued and outstanding shares of ... Thursday, February 11, 2016. The Company,s common stock will ... 76303T308 and temporary ticker symbol "RCHAD". After 20 trading ... ticker symbol (RCHA).  --> ...
(Date:2/10/2016)... 2016  Oxis International Inc. (OTC/QB: OXIS) announced today ... as a "clinical trial triumph" after one of the ... cancer remission. Daniel Vallera , a ... Center. --> Daniel Vallera , a ... Center. --> An article on the ...
(Date:2/10/2016)... Feb. 10, 2016  The ALS Association, in partnership with ... Challenge to generate a biomarker to track TDP43 aggregation. The ... to a $1 million investment. --> ... that affects nerve cells in the brain and the spinal ... and control muscle movement, which often leads to total paralysis ...
Breaking Medicine Technology: